We strive to provide a culture in which employees flourish, and talents excel.
Established in 1994 in Saudi Arabia, Tabuk Pharmaceuticals’ fast growth has allowed it to become a global company, with a strong focus on the Middle East and North Africa region.
We want to differentiate ourselves at every level, and most importantly, remain focused on the needs of our patients. Tabuk Pharmaceuticals was established in 1994 in Riyadh, The Kingdom of Saudi Arabia.
Since we are subjects to importation quotas, it is hard to achieve the full potential of a company relying on the imported products market, because the quotas are low. Algeria can become a hub in the Maghreb region and to other African countries for all sectors.The R&D department allow us to innovate and bring added value. Tabuk Pharmaceuticals develops, manufactures, markets and distributes branded generic pharmaceuticals and under-licensed products globally. Tabuk Pharmaceuticals. 239 talking about this. We want to differentiate from the others. 146 talking about this. Tabuk is centered on answering the needs of the patients, and it is proof that even generics specialists have a responsibility to innovate.We will soon launch a number of products but as for now Divido© and the cephalosporins are certainly the most efficient on the market.
We want to support the Algerian families in their daily life.
In the future, every household’s medicine cabinet will contain at least one or several of Tabuk’s products.
Tabuk Pharmaceuticals Tabuk #pharma develops, manufactures, markets and distributes branded #generic & under-licensed products globally, with a strong focus in #MENA www.tabukpharmaceuticals.com
Patient associations and doctor associations reached out to us after we were forbidden to import several Tabuk solutions produced elsewhere. Get up-to-date business information, contact details, latest news and press releases and people contacts on ZAWYA MENA Edition It did not prevent us from investing here and from following the authority’s guidelines in that matter. 10 years ago, even European generics were struggling. Last July, after a long period of status quo, we were granted a quota on cephalosporin imports, because they were able to measure the impact on the market: one manufacturer could not answer all the demand of the domestic market. Commensurately, profitability was maintained. What changes would Akthaboot have to make for you to give it a higher rating? We planned for an opening in January with no imports yet, and after everything we were granted an import quota, which was a victory. This site is for senior professionalswho want to understand local and global markets.Clearly, Algeria is a specific market.
Every day is different. We want to develop the added value. The Algerian market is both exciting and stable enough to plan for the future. Our policy is very clear when it comes to drug prescription: Algeria is very much inspired by the French model, while Tabuk has a more anglo-saxon identity.
The mindset has changed, so our patients and doctors are no longer refractory to generic drugs. They answered quickly to the Algerian economic situation by investing in manufacturing and made the leap in good faith for the good of the Algerian patient. For a long time, a lot of multinational companies marketed their original drugs to the physicians only, and not to the final users – the patients, or even the pharmacies. Additionally, we will develop our image and our message that generics can be innovative, as innovative and reliable as the original drugs.Ipsen’s Guillaume Freneuil gives his take on the importance of the Algerian market to the global group. Tabuk Pharmaceuticals is a very stable company .. and has very good relations with its customers Cons At this critical point of Saudization of the job of pharmaceuticals, I think, and may be I'm wrong, that they cared less about the employees Then in 2014, the Minister authorized us to go forward.
First we would only import and market around ten of Tabuk’s products in Algeria. Yet, it goes without saying, that as a player in the pharmaceutical field, we respect and follow the political decisions that are taken for the good of the country.
They really manage to balance the decisions between economical constraints, patients’ needs, administrative and production delays or industrial realities. شركة سعودية رائدة في مجال الصناعات الدوائية، ذات انتشار إقليمي في منطقة الشرق الأوسط وشمال أفريقيا What changes would Akthaboot have to make for you to give it a higher rating?
Second, it is not always easy nowadays to gain access to the market, because the number of players has increased and quotas do not solve everything.